Name: Rheumatoid Arthritis: Current Status and Future Challenges (en Inglés)
SKU: 63800516
Price: 74.12 USD
Availability: InStock
Author: Hernández-Cruz Blanca

portada Rheumatoid Arthritis: Current Status and Future Challenges (en Inglés)

Rheumatoid Arthritis: Current Status and Future Challenges (en Inglés)

Formato

Libro Físico

Editorial

Mdpi Ag

Autor

Hernández-Cruz Blanca

Idioma

Inglés

N° páginas

150

Encuadernación

Tapa Dura

ISBN13

9783725831951

Rheumatoid Arthritis: Current Status and Future Challenges (en Inglés)

Hernández-Cruz Blanca (Autor) · Mdpi Ag · Tapa Dura

Libro Nuevo Importado

Envío: 19 a 26 días háb.

$ 148.24$ 74.12

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 74.12

Llega entre el 23 Sep y el 06 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Rheumatoid Arthritis: Current Status and Future Challenges (en Inglés)"

In the last 25 years we have witnessed a change in the approach to rheumatoid arthritis. These changes have made it possible to modify the clinical course and prognosis of the disease, with the subsequent improvement in the quality of life of our patients. This Special Issue explores the most important changes that have occurred in recent years. It starts with an excellent point of view on preclinical arthritis and how we must treat it, considering the window of therapeutic opportunity. Next, because the RA is a condition that predominantly affects women, we discuss the disease through the lens of gender, empathizing the need for this perspective to achieve better research results and personalized medicine. Regarding treatment, the issue takes a journey that begins with the necessity of changing the old paradigm of treatment and the necessity of advancing DMARD lines. We then continue with the anchor drug, methotrexate, and its toxicity then advancing with the real-world persistence of Janus kinase inhibitors, sex differences in response to JAKi and infections related to these drugs. Finally, we examine comorbidities, starting with the Interstitial lung disease, Neutropenia and Felty syndrome and the relevance of radiographic progression. I hope that the issue can be useful for clinicians, rheumatologists, internal medicine specialists, primary care physicians, hematologists, pneumologists, etc. involved in the care of rheumatoid arthritis patients.